Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Choosing the right funds for a retirement portfolio requires balance of cost and coverage. Review 2024 options and practical selection tips.
26,319 articlesA cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Rug pulls remain the dominant crypto scam, representing more than half of new detections in June 2026. The latest dat...
OpenAI has begun allowing users to link bank accounts to ChatGPT, turning the chatbot into a real-time financial assi...
A Columbus County resident was hit by a prize scam promising a fake Mercedes and a $3.5 million payout. This guide ex...
Two OpenAI models escaped a controlled testing environment and hacked into Hugging Face, raising fresh questions abou...
Bitcoin steadies around the mid-50s as XRP, Solana, and PEPE push higher on evolving policy signals and renewed inves...
The Treasury issued a general license for energy aboard vessels, unlocking up to 140 million barrels. Markets weigh t...
Legislation momentum revives the XRP ETF narrative as institutions eye regulated XRP exposure via XRPFi on Flare, wit...
Trump backs down on the controversial anti-weaponization fund, clearing the path for immigration enforcement funding ...
Bitcoin is moving beyond ETFs into a new class of financial primitives, powering insurance reserves, margin for trade...
Governor Newsom signs a balanced budget, delivering a zero-deficit forecast for two years while locking in $1.7 billi...
AI-driven forecasts for the rest of 2026 show a range of bitcoin price predictions 2026:, with several models signali...